Business

Aurobindo Pharma Q1 results: Profit drops 10% to ₹824 crore on US sales

The Hyderabad-based drug maker posted a net profit of ₹918 crore for the April-June quarter of last fiscal

​The Hyderabad-based drug maker posted a net profit of ₹918 crore for the April-June quarter of last fiscal 

Related posts

Global Market Today: Oil jumps, stocks wobble as Mideast ceasefire hangs in the balance(Soban News)

News-Soban-Admin

Wall Street closes lower, pausing record-setting rally as earnings approach(Soban News)

News-Soban-Admin

Tata Capital shares edge lower after flat debut. Should you buy, sell or hold the stock?(Soban News)

News-Soban-Admin

Leave a Comment